New Partnership with Cerebral Palsy Alliance

We’re excited to announce a new partnership with the Cerebral Palsy Alliance and are proud to be supporting this important research.

New Partnership with Cerebral Palsy Alliance

February 24, 2022
We’re excited to announce a new partnership with the Cerebral Palsy Alliance and are proud to be supporting this important research.
Read Transcript

Cerebral Palsy Alliance Research Foundation partners with Hearts & Minds Investments to deliver ground-breaking newborn care technology

 

Cerebral Palsy Alliance Research Foundation (CPA) and Hearts & Minds Investments Limited are delighted to announce a significant new partnership, supporting innovative research that aims to revolutionise newborn intensive care around the world.

The partnership will initially support a program of research into projects that aim to reduce disability and death in seriously ill babies – including a study on brain injuries in newborns caused by lack of oxygen, which is among the first of its kind in the world. It will also support some of Australia’s leading research and health professionals in neonatology and bioengineering to reduce the incidence and severity of cerebral palsy and other lifelong disabilities in children.

A leading ASX-listed investment company with a unique philanthropic focus, Hearts & Minds Investments (ASX: HM1) donates 1.5% of the total value of its managed portfolio every year to Australian medical research institutes.

The first project, known as Virtual Baby, will use innovative artificial intelligence systems to reduce the risk of permanent brain damage in newborns.

A collaborative team of intensive care experts from Cerebral Palsy Alliance Research Foundation, the Children’s Hospital at Westmead (Sydney Children’s Hospital Network), CSIRO eHealth and Westmead Neonatal Intensive Care Unit, led by Senior Newborn Intensive Care Specialist Dr Mark Tracy, have created a unique database containing more than 1.2 million patient hours with the goal of unearthing hidden patterns of illness.

By feeding this data into Virtual Baby, predictive computer modelling will be able identify the warning signs in blood pressure, heart rate, oxygen levels and other health data before clinical observation can. This data can then be used by doctors and nurses to intervene earlier and improve outcomes for babies in intensive care.

The support of Hearts & Minds Investments will enable a staged expansion of this project at the Westmead campus from Westmead’s neonatal intensive care unit (NICU) to the Westmead Children’s Hospital NICU. Longer-term plans will include the development of open-access software to be shared with all NICU units in Australia and virtual training for staff.

A team of Australian researchers and health professionals are launching two world-first projects to prevent disability and death in newborns, enabled by a new partnership between Cerebral Palsy Alliance Research Foundation and Hearts & Minds Investments.

"Smart monitoring, smart prediction and smart training is the future for humanity – utilising big data and advanced artificial intelligence to analyse and understand patterns, we can predict illness before it happens. The Hearts & Minds and Cerebral Palsy Alliance partnership is the most amazing start to this research project,” said Dr Tracy.

The Hearts & Minds partnership will also enable an innovative research trial into how advanced monitoring of oxygen levels in the brain may assist in protecting vulnerable newborns from brain injury.

While there are many causes of cerebral palsy, brain injuries in newborn babies caused by a lack of oxygen are known to be a major contributor. In Australia, 13 out of 14 cases of cerebral palsy occur in the uterus or before one month of age, meaning babies in NICU are at the greatest risk.

Conducted by a team led by Westmead Hospital’s Dr Pranav Jani, the study will be among the first of its kind and has the potential to prevent cerebral palsy in vulnerable babies, therefore improving learning, development and quality of life.

In partnering with Hearts & Minds, Cerebral Palsy Alliance Research Foundation joins some of the most prestigious and impactful research institutes in Australia, including the Victor Chang Cardiac Research Institute, Black Dog Institute and Royal Prince Alfred Hospital’s Green Light Institute.

“Hearts & Minds is an investment company with a difference, in that we provide both investment returns and social returns. We chose to fund CPA based on their track record of improving the outcomes of children born with, or at the risk of, cerebral palsy. We are confident that our research partnership will lead to further improvements in the diagnosis and treatment of vulnerable newborns,” said Paul Rayson, Chief Executive Officer of Hearts & Minds Investments.

Since being established in 2005, Cerebral Palsy Alliance Research Foundation has been dedicated to accelerating the treatment and prevention of cerebral palsy, the most common physical disability in childhood. More than 34,000 Australians have cerebral palsy, and 17 million people worldwide live with the condition.

Professor Nadia Badawi AM, Medical Director and Co-Head, Grace Centre for Newborn Intensive Care at The Children’s Hospital at Westmead and CP Alliance Chair of Cerebral Palsy Research, The University of Sydney, said the projects enabled by Hearts & Minds would transform clinical newborn care.

“In the last 20 years, the survival rate of babies in our NICU has gone from 80% to over 97%. This extraordinary progress has been enabled by funding from the community, donors and visionary organisations such as Hearts & Minds. This partnership will help us to continue to deliver the best research in the world and get the best possible outcome for sick children and their families.”

“These two projects will have a profound impact on the standard of care for critically ill newborn babies, and we thank Hearts & Minds Investments for their commitment to scientific excellence and look forward to a long and worthwhile partnership,” said Professor Badawi.

Both projects will be overseen by a multidisciplinary collaboration between experts from Cerebral Palsy Alliance Research Institute and the University of Sydney’s Brain and Mind Centre, primarily based at the Children’s Hospital Westmead.

 

 

Disclaimer: this communication has been prepared by Hearts and Minds Investments Limited (ABN 61 628 753 220) and may contain general information relating to HM1 securities. The general information should not be considered financial advice. HM1 is not licensed to provide financial product advice. The information does not consider the investment objectives, financial situation, or particular needs of any individual. The information is current as at the date of preparation and is subject to change. HM1 does not guarantee repayment of capital or any rate of return on HM1 securities. An investment may achieve a lower-than-expected return and investors risk losing some, or all, of their principal investment. Past performance is not a reliable indicator of future performance. This document may not be reproduced or copies circulated without prior authority from Hearts and Minds Investments Limited.

Cerebral Palsy Alliance Research Foundation partners with Hearts & Minds Investments to deliver ground-breaking newborn care technology

 

Cerebral Palsy Alliance Research Foundation (CPA) and Hearts & Minds Investments Limited are delighted to announce a significant new partnership, supporting innovative research that aims to revolutionise newborn intensive care around the world.

The partnership will initially support a program of research into projects that aim to reduce disability and death in seriously ill babies – including a study on brain injuries in newborns caused by lack of oxygen, which is among the first of its kind in the world. It will also support some of Australia’s leading research and health professionals in neonatology and bioengineering to reduce the incidence and severity of cerebral palsy and other lifelong disabilities in children.

A leading ASX-listed investment company with a unique philanthropic focus, Hearts & Minds Investments (ASX: HM1) donates 1.5% of the total value of its managed portfolio every year to Australian medical research institutes.

The first project, known as Virtual Baby, will use innovative artificial intelligence systems to reduce the risk of permanent brain damage in newborns.

A collaborative team of intensive care experts from Cerebral Palsy Alliance Research Foundation, the Children’s Hospital at Westmead (Sydney Children’s Hospital Network), CSIRO eHealth and Westmead Neonatal Intensive Care Unit, led by Senior Newborn Intensive Care Specialist Dr Mark Tracy, have created a unique database containing more than 1.2 million patient hours with the goal of unearthing hidden patterns of illness.

By feeding this data into Virtual Baby, predictive computer modelling will be able identify the warning signs in blood pressure, heart rate, oxygen levels and other health data before clinical observation can. This data can then be used by doctors and nurses to intervene earlier and improve outcomes for babies in intensive care.

The support of Hearts & Minds Investments will enable a staged expansion of this project at the Westmead campus from Westmead’s neonatal intensive care unit (NICU) to the Westmead Children’s Hospital NICU. Longer-term plans will include the development of open-access software to be shared with all NICU units in Australia and virtual training for staff.

A team of Australian researchers and health professionals are launching two world-first projects to prevent disability and death in newborns, enabled by a new partnership between Cerebral Palsy Alliance Research Foundation and Hearts & Minds Investments.

"Smart monitoring, smart prediction and smart training is the future for humanity – utilising big data and advanced artificial intelligence to analyse and understand patterns, we can predict illness before it happens. The Hearts & Minds and Cerebral Palsy Alliance partnership is the most amazing start to this research project,” said Dr Tracy.

The Hearts & Minds partnership will also enable an innovative research trial into how advanced monitoring of oxygen levels in the brain may assist in protecting vulnerable newborns from brain injury.

While there are many causes of cerebral palsy, brain injuries in newborn babies caused by a lack of oxygen are known to be a major contributor. In Australia, 13 out of 14 cases of cerebral palsy occur in the uterus or before one month of age, meaning babies in NICU are at the greatest risk.

Conducted by a team led by Westmead Hospital’s Dr Pranav Jani, the study will be among the first of its kind and has the potential to prevent cerebral palsy in vulnerable babies, therefore improving learning, development and quality of life.

In partnering with Hearts & Minds, Cerebral Palsy Alliance Research Foundation joins some of the most prestigious and impactful research institutes in Australia, including the Victor Chang Cardiac Research Institute, Black Dog Institute and Royal Prince Alfred Hospital’s Green Light Institute.

“Hearts & Minds is an investment company with a difference, in that we provide both investment returns and social returns. We chose to fund CPA based on their track record of improving the outcomes of children born with, or at the risk of, cerebral palsy. We are confident that our research partnership will lead to further improvements in the diagnosis and treatment of vulnerable newborns,” said Paul Rayson, Chief Executive Officer of Hearts & Minds Investments.

Since being established in 2005, Cerebral Palsy Alliance Research Foundation has been dedicated to accelerating the treatment and prevention of cerebral palsy, the most common physical disability in childhood. More than 34,000 Australians have cerebral palsy, and 17 million people worldwide live with the condition.

Professor Nadia Badawi AM, Medical Director and Co-Head, Grace Centre for Newborn Intensive Care at The Children’s Hospital at Westmead and CP Alliance Chair of Cerebral Palsy Research, The University of Sydney, said the projects enabled by Hearts & Minds would transform clinical newborn care.

“In the last 20 years, the survival rate of babies in our NICU has gone from 80% to over 97%. This extraordinary progress has been enabled by funding from the community, donors and visionary organisations such as Hearts & Minds. This partnership will help us to continue to deliver the best research in the world and get the best possible outcome for sick children and their families.”

“These two projects will have a profound impact on the standard of care for critically ill newborn babies, and we thank Hearts & Minds Investments for their commitment to scientific excellence and look forward to a long and worthwhile partnership,” said Professor Badawi.

Both projects will be overseen by a multidisciplinary collaboration between experts from Cerebral Palsy Alliance Research Institute and the University of Sydney’s Brain and Mind Centre, primarily based at the Children’s Hospital Westmead.

 

 

Disclaimer: this communication has been prepared by Hearts and Minds Investments Limited (ABN 61 628 753 220) and may contain general information relating to HM1 securities. The general information should not be considered financial advice. HM1 is not licensed to provide financial product advice. The information does not consider the investment objectives, financial situation, or particular needs of any individual. The information is current as at the date of preparation and is subject to change. HM1 does not guarantee repayment of capital or any rate of return on HM1 securities. An investment may achieve a lower-than-expected return and investors risk losing some, or all, of their principal investment. Past performance is not a reliable indicator of future performance. This document may not be reproduced or copies circulated without prior authority from Hearts and Minds Investments Limited.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
December 5, 2023

Prof Daniel MacArthur | Sohn Hearts & Minds Conference

At this year's Sohn Hearts & Minds Conference, we heard from Prof Daniel MacArthur, the Director of the Centre for Population Genomics.

Read More
December 5, 2023

Prof Michelle Simmons AO | Sohn Hearts & Minds Conference

At this year's Sohn Hearts & Minds Conference, we heard from Prof Michelle Simmons, the CEO and Founder of Silicon Quantum Computing.

Read More
December 5, 2023

Prof Misty Jenkins AO | Sohn Hearts & Minds Conference

At this year's Sohn Hearts & Minds Conference, we heard from Prof Misty Jenkins. Misty is a NHMRC fellow and laboratory head of the Immunology Division at the Walter and Eliza Hall Institute.

Read More
December 4, 2023

Is dementia truly preventable?

In this NeuRA Talk, Professor Kaarin Anstey, Dr Nikki-Anne Wilson and Dr Bill Brooks are joined by Executive Director of Professional Services, Carole Renouf to answer the question: Is dementia truly preventable?

Read More
November 10, 2023

Big thinkers in hunt for brain cancer cure

“Brain cancer is rare, but for people who do get it the prognosis is not good,” Assistant Professor Jenkins tells The Australian.

Read More
November 6, 2023

Genomic medicine the future of health?

DNA sequences may well hold the secrets to better health. Profound changes in the practice of medicine are underway, being driven by rapid developments in several fields, particularly in genomics.

Read More
October 3, 2023

WA scientists win Hearts and Minds

We’re excited to announce that we have made our first donation to a beneficiary in Western Australia, Harry Perkins Institute of Medical Research.

Read More
Left to right: Mike Lawrence, Nicholas Kirk and Mai MargettsLeft to right: Mike Lawrence, Nicholas Kirk and Mai MargettsLeft to right: Mike Lawrence, Nicholas Kirk and Mai MargettsLeft to right: Mike Lawrence, Nicholas Kirk and Mai Margetts
July 14, 2023

Could insulin come in a pill? How a molecule that mimics insulin may advance diabetes research

WEHI researchers have answered a 100-year-old question in diabetes research: can a molecule different to insulin have the same effect?

Read More
May 8, 2023

The Florey. Where remarkable minds advance brain research.

The Florey is the home of neuroscience and mental health research, advancing knowledge of the brain to improve health outcomes for us all. Learn more about their organisation here.

Read More
May 5, 2023

Medicare Heart Health Check Saved

The Victor Chang Cardiac Research Institute says that the Federal Government's decision to extend Medicare-funded Heart Health Checks will save lives.

Read More
Merilyn Oakes and Professor Michael Feneley. Picture: John FederMerilyn Oakes and Professor Michael Feneley. Picture: John FederMerilyn Oakes and Professor Michael Feneley. Picture: John FederMerilyn Oakes and Professor Michael Feneley. Picture: John Feder
April 20, 2023

Artificial intelligence gives new hope for sufferers of severe heart problem

New AI software can improve the diagnosis of severe aortic stenosis by 72% and could potentially change the lives of about 50,000 Australians with the life-threatening condition.

Read More
April 20, 2023

Innovation Centre's key role in delivering new stroke treatments

The Innovation Centre at the Victor Chang Cardiac Research Institute has been very useful for Dr Kirsten Coupland from the University of Newcastle to help her shed light on the inner workings of the brain.

Read More
April 13, 2023

Saving Hearts to Save Lives

Professor Peter Macdonald from the Victor Chang Cardiac Research Institute opens up about his career as a cardiologist and scientist, the groundbreaking 'Heart in a Box', and the potential of deadly spider venom.

Read More
March 7, 2023

Case Study Highlight: The Baker Heart & Diabetes Institute

Working closely with Indigenous communities, The Baker Heart and Diabetes Institute is working to help tackle heart disease and diabetes in remote communities of Central Australia.

Read More
February 21, 2023

A Heart in a Box: The Gift of Life

A “heart in a box”. It sounds like an ad for Valentine’s Day chocolates. But this box contains an actual human heart which is pumping outside its original body, enabling the gift of life from one person to another.

Read More